Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 2012 Biotech Stock Predictions: An Interim Report Card
2012 Biotech Stock Predictions: An Interim Report Card
2012 Biotech Stock Predictions: An Interim Report Card
Submitted by
admin
on August 28, 2012 - 11:07am
Source:
TheStreet.com
News Tags:
Cell Therapeutics
Momenta
Onyx
Amag Pharmaceuticals
Biomarin
M&A
Celgene
Seattle Genetics
Galena Biopharma
ImmunoCellular
Amgen
Celldex
Dendreon
GSK
Vical
Oncothyreon
Biogen Idec
Merck KGaA
Bristol-Myers Squibb
Allos
Spectrum Pharmaceuticals
AstraZeneca
Headline:
2012 Biotech Stock Predictions: An Interim Report Card
Do Not Allow Advertisers to Use My Personal information
